Short answer: No, there is no generic version of Ibsrela available on the market today.
---
What is Ibsrela?
- Brand name: Ibsrela
- Active ingredient: Budesonide 7.5 mg
- Formulation: Oral capsules designed to deliver budesonide directly to the terminal ileum for the treatment of mild to moderate Crohn’s disease involving the ileum and/or right colon.
- Manufacturer: Bausch & Lomb (formerly).
Ibsrela was approved by the FDA in 2015 as a convenient, once‑daily capsule that targets the ileum to reduce inflammation while minimizing systemic steroid exposure.
---
Why there is no generic
1. Voluntary withdrawal
- In 2017 Bausch & Lomb voluntarily withdrew Ibsrela from the U.S. market.
- The decision was driven by a combination of lower-than‑expected sales, regulatory and safety concerns, and the availability of other effective budesonide preparations.
2. No approved generic
- Because the original product was withdrawn and has not been re‑approved, no generic entry has been granted or marketed.
- The FDA has not cleared a generic version of the exact 7.5 mg ileum‑targeted capsule.
---
Alternatives you can still use
| Category | Product | How it differs from Ibsrela | Typical Use |
|----------|---------|---------------------------|-------------|
| Generic budesonide | Budesonide 3 mg (e.g., Entocort EC) | Released for the ileo‑colonic portion; not ileum‑specific capsule, but enteric‑coated for ileum‑colonic release. | Mild to moderate Crohn’s disease of the ileum and colon. |
| Generic budesonide | Budesonide 6 mg (e.g., Uceris) | Enteric‑coated 6 mg tablets; similar targeted release. | Mild to moderate Crohn’s disease of the ileum and colon. |
| Generic budesonide | Budesonide 1 mg (e.g., Budevia) | 1 mg capsule for ulcerative colitis; not used for Crohn’s ileal disease. | Mild ulcerative colitis. |
| Alternative oral steroid | Prednisone or prednisolone | Systemic steroids; higher systemic exposure and more side‑effects. | Short‑term flare‑up control. |
If your clinician prescribed Ibsrela, they likely wanted a once‑daily, ileum‑targeted budesonide. In practice, many prescribers now use the generic 6 mg budesonide tablets (Entocort EC) because they provide the same ileal/colonic targeting with an established safety profile.
---
What to do next
1. Discuss with your provider
- Ask whether a generic budesonide (6 mg Entocort EC) would be a suitable substitute.
- Discuss dosing, timing (usually once daily), and monitoring for side‑effects.
2. Consider other options
- If the disease is more extensive or severe, your clinician might recommend biologics (e.g., anti‑TNF agents) or small‑molecule therapies (e.g., Janus kinase inhibitors).
3. Check insurance coverage
- Generic budesonide is usually covered as a first‑line therapy for mild to moderate Crohn’s. Your insurance may also cover the 6 mg formulation.
---
Bottom line
- Ibsrela itself is not on the market and no generic is approved.
- Generic budesonide (6 mg) is widely available and often used as the practical replacement.
- Talk to your gastroenterologist or pharmacist to confirm the best regimen for your specific situation.